TTNP : Summary for Titan Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets closed

Titan Pharmaceuticals, Inc. (TTNP)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.35+0.05 (+1.52%)
At close: 4:00PM EDT
People also watch
VNDABDSIIMUCONCSAEZS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close3.30
Open3.30
Bid2.75 x 100
Ask3.65 x 500
Day's Range3.30 - 3.40
52 Week Range3.15 - 8.74
Volume98,409
Avg. Volume92,644
Market Cap71.02M
Beta1.59
PE Ratio (TTM)16.67
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Titan Pharmaceuticals, Inc. :TTNP-US: Earnings Analysis: 2016 By the Numbers : March 20, 2017
    Capital Cube6 days ago

    Titan Pharmaceuticals, Inc. :TTNP-US: Earnings Analysis: 2016 By the Numbers : March 20, 2017

    Categories: Yahoo Finance Get free summary analysis Titan Pharmaceuticals, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Titan Pharmaceuticals, Inc. – Vanda Pharmaceuticals Inc., Celldex Therapeutics, Inc., DURECT Corporation, Paratek Pharmaceuticals Inc, Novartis AG Sponsored ADR, Johnson & Johnson and Elite Pharmaceuticals, Inc. (VNDA-US, CLDX-US, ... Read more (Read more...)

  • Associated Press10 days ago

    Titan Pharmaceuticals reports 4Q loss

    The South San Francisco, California-based company said it had a loss of 15 cents per share. The specialty pharmaceutical company posted revenue of $35,000 in the period. For the year, the company reported ...

  • Titan Pharmaceuticals Reports Full Year And Fourth Quarter 2016 Financial Results
    PR Newswire10 days ago

    Titan Pharmaceuticals Reports Full Year And Fourth Quarter 2016 Financial Results

    SOUTH SAN FRANCISCO, Calif., March 16, 2017 /PRNewswire/ --  Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing ...